Abstract
Intracellular calcium ([Ca2+] i ) is highly regulated in eukaryotic cells. The free [Ca2+] i is approximately four orders of magnitude less than that in the extracellular environment. It is, therefore, an electrochemical gradient favoring Ca2+ entry, and transient cellular activation increasing Ca2+ permeability will lead to a transient increase in [Ca2+] i . These transient rises of [Ca2+] i trigger or regulate diverse intracellular events, including metabolic processes, muscle contraction, secretion of hormones and neurotransmitters, cell differentiation, and gene expression. Hence, changes in [Ca2+] i act as a second messenger system coordinating modifications in the external environment with intracellular processes. Notably, information on the molecular genetics of the membrane channels responsible for the influx of Ca2+ ions has led to the discovery that mutations in these proteins are linked to human disease. Ca2+ channel dysfunction is now known to be the basis for several neurological and muscle disorders such as migraine, ataxia, and peri odic paralysis. In contrast to other types of genetic diseases, Ca2+ channelopathies can be studied with precision by electrophysiological methods, and in some cases, the results have been highly rewarding with a biophysical phenotype that correlates with the ultimate clinical phenotype. This review outlines recent advances in genetic, molecular, and pathophysiological aspects of human Ca2+ channelopathies.
Similar content being viewed by others
References
Adams B. A., and Beam K G. (1990) Muscular dys genesis in mice: a model system for studying excitation-contraction coupling. FASEB J. 4, 2809–2816.
Arikkath J., and Campbell K. P. (2003) Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr. Opin. Neurobiol. 13, 298–307.
Bain P. G., O'Brien M. D., Keevil F., and Porter D. A. (1992) Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann. Neurol. 31, 147–154.
Ball S. L., and Gregg R. G. (2002) Using mutant mice to study the role of voltage-gated calcium channels in the retina. Adv. Exp. Med. Biol. 514, 439–450.
Ball S. L., Powers P. A., Shin H. S., Morgans C. W., Peachey N. S., and Gregg R. G. (2002) Role of the β2 subunit of voltage-dependent calcium channels in the retinal outer plexiform layer. Invest. Ophthalmol. Vis. Sci. 43, 1595–1603.
Baloh R. W. and Jen J. C. (2002) Genetics of familial episodic vertigo and ataxia. Ann. NY Acad. Sci. 956, 338–345.
Bech-Hansen N. T., Boycott K. M., Gratton K. J., Ross D. A., Field L. L., and Pearce W. G. (1998a) Local ization of a gene for incomplete X-linked congenital stationary night blindness to the interval between DXS6849 and DXS8023 in Xp11.23. Hum. Genet. 103, 124–130.
Bech-Hansen N. T., Naylor M. J., Maybaum T. A., et al. (1998b) Loss-of-function mutations in a calcium-channel α1 subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat. Genet. 19, 264–267.
Birnbaumer L., Campbell K. P., Catterall W. A., et al. (1994) The naming of voltage-gated calcium channels. Neuron 13, 505, 506.
Black J. L. 3rd. (2003) The voltage-gated calcium channel γ subunits: a review of the literature. J. Bioenerg. Biomembr. 35, 649–660.
Boycott K. M., Maybaum T. A., Naylor M. J., et al. (2001) Asummary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants. Hum. Genet. 108, 91–97.
Brooks C., Robinson R. L., Halsall P. J., and Hopkins P. M. (2002) No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia population. Br. J. Anaesth. 88, 587–589.
Catterall W. A. (2000) Structure and regulation of voltage-gated Ca2+ channels. Annu. Rev. Cell Dev. Biol. 16, 521–555.
Catterall W.A., Perez-Reyes E., Snutch T. P., and Striessnig J. (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57, 411–425.
Chartrand D. (2003) Rapid intervention for an episode of malignant hyperthermia. Can. J. Anaesth 50, 104–107.
Chen X. H., Bezprozvanny I., and Tsien R. W. (1996) Molecular basis of proton block of L-type Ca2+ channels. J. Gen. Physiol. 108, 363–374.
Christopher A. R. (1997) Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147–1150.
Davies N. P. and Hanna M. G. (2001) The skeletal muscle channelopathies: basic science, clinical genetics and treatment. Curr. Opin. Neurol. 14, 539–351.
Dirksen R. T. (2002) Bi-directional coupling between dihydropyridine receptors and ryanodine receptors. Front. Biosci. 7, d659-d670.
Doering C. J. and Zamponi G. W. (2003) Molecular pharmacology of high voltage-activated calcium channels. J. Bioenerg Biomembr. 35, 491–505.
Dolphin A. C. (2003) β subunits of voltage-gated calcium channels. J. Bioenerg. Biomembr. 35, 599–620.
Ertel E. A., Campbell K. P., Harpold M. M., et al. (2000) Nomenclature of voltage-gated calcium channels. Neuron 25, 533–535.
Felix R. (1999) Voltage-dependent Ca2+ channel α2δ auxieiary subunit: structure, function and regulation. Receptor Channel 6, 351–362.
Felix R. (2000) Channelopathies: ion channel defects linked to heritable clinical disorders. J. Med. Genet. 57, 729–740.
Felix, R. (2002) In sights from mouse models of absence epilepsy into Ca2+ channel physiology and disease efiology. Cell Mol. Neurobiol. 22, 103–120.
Fontame B., Vale-Santos J., Jurkat-Rott K., et al. (1994) Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31–32 in three European families. Nat. Genet. 6, 267–272.
Friend K. L., Crimmins D., Phan T. G., et al. (1999) Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM. Hum. Genet. 105, 261–265.
Geschwind D. H., Perlman S., Figueroa C. P., Treiman L. J., and Pulst S. M. (1997) The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am. J. Hum. Genet. 60, 842–850.
Grafe P., Quasthoff S., Strupp M., and Lehmann-Horn F. (1990) Enhancement of K+ conductance improves in vitro the contraction force of skeletal muscle in hypokalemic, periodic paralysis. Muscle Nerve 13, 451–457.
Griggs R. C., Moxley R. T. 3rd., Lafrance R. A., and McQuillen J. (1978) Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 28, 1259–1264.
Guida S., Trettel F., Pagnutti S., et al. (2001) Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68, 759–764.
Hille B. (2001) Ion channels of excitable membranes. 3rd ed., Sinauer Associates Inc. Sunderland, MA.
Iles D. E., Lehmann-Horn F., Scherer S. W., et al (1994). Localization of the gene encoding the α2/δ-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia sus ceptible families. Hum. Mol. Genet. 3, 969–975.
Ishikawa K., Fujigasaki H., Saegusa H., et al. (1999) Abundant expression and cytoplasmic aggregations of α1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet. 8, 1185–1193.
Ishikawa K., Tanaka H., Saito M., et al. (1997) Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1–p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1. Am. J. Hum. Genet. 61, 336–346.
Jacobi F. K., Hamel C. P., Arnaud B., et al. (2003) A novel CACNA1F mutation in a french family with the incomplete type of X-linked congenital stationary night blindness. Am. J. Ophthalmol. 135, 733–736.
Jen J., Wan J., Graves M., et al. (2001) Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57, 1843–1848.
Jen J., Yue Q., Nelson S. F., et al. (1999) A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia. Neurology 53, 34–37.
Jodice C., Mantuano E., Veneziano L., et al. (1997) Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19P. Hum. Mol. Genet. 6, 1973–1978.
Jun K., Piedras-Renteria E. S., Smith S. M., et al. (1999) Ablation of P/Q-type Ca2+ channel currents altered synaptic transmission, and progressive ataxia in mice lacking the α1-subunit. Proc. Natl. Acad. Sci. USA 96, 15,245–15,250.
Jurkat-Rott K., Lerche H., and Lehmann-Horn F. (2002) Skeletal muscle channelopathies. J. Neurol. 249, 1493–1502.
Kaja S., van de Ven R. C., Broos L. A., et al. (2005) Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135, 81–95.
Kang M. G., Chen C. C., Felix R., et al. (2001) Biochemical and biophysical evidence for β2 subunit association with neuronal voltage-activated Ca2+ channels. J. Biol. Chem. 276, 32,917–32,924.
Kang M. G. and Campbell K. P. (2003) Gamma subunit of voltage-activated calcium channels. J. Biol. Chem. 278, 21,315–21,318.
Klugbauer N., Marais E., and Hofmann F. (2003) Calcium channel α2δ subunis: Differential expression, function, and drug binding. J. Bioenerg. Biomembr. 35, 639–647.
Kraus R.L., Sinnegger M. J., Glossmann H., Hering S., and Striessnig J. (1998) Familial hemiplegic migraine mutations change α1A Ca2+ channel kinetics. J. Biol. Chem. 273, 5586–5590.
Lacinovia L. (2005) Voltage-dependent calcium channels. Gen. Physiol. Biophys. 24(Suppl 1), 1–78.
Lupie P., Goudet C., Nargeot J., Fontaine B., and Lory P. (1996) Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle α1S subunit as expressed in mouse L cells. FEBS Lett. 382, 244–248.
Lorenzon N. M. and Beam K. G. (2000) Calcium channelopathies. Kidney Int. 57, 794–802.
MacLennan D. H., Phillips M. S., and Zhang Y. (1996) The genetic and physiological basis of malignant hyperthermia. in Molecular Biology of Membrane Transport Disorders, 2nd ed., Schultz S. G., Andreoli T. E., Brown A. M., Fambrough D. M., Hoffman J. F., and Welsh M. J., eds., Plenum Press, New York.
Maselli R. A., Books W., and Dunne V. (2003) Effect of inherited abnormalities of calcium regulation on human neuromuscular transmission. Ann. NY Acad. Sci. 998, 18–28.
Matsuyama Z., Wakamori M., Mori Y., Kawakami H., Nakamura S., and Imoto K. (1999) Direct alteration of the P/Q-type Ca2+ channel property by polygfutamine expansion in spinocerebellar ataxia 6. J. Neurosci. 19, RC14:1–5.
Matsuyama Z., Kawakami H., Maruyama H., et al. (1997) Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6). Hum. Mol. Genet. 6, 1283–1287.
Monnier N., Procaccio V., Stieglitz P., and Lunardi J. (1997) Malignant-hyperthermia susceptibility is associated with a mutation of the α1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet. 60, 1316–1325.
Monnier N., Krivosic-Horber R., Payen J. F., et al. (2002) Presence of two different genetic traits in malignanthyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anethestiology 97, 1067–1074.
Monnier N., Romero N. B., Lerale J., et al. (2000) An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum. Mol. Genet. 9, 2599–2608.
Morgans C. W., Gaughwin P., and Maleszka R. (2001) Expression of the α1F calcium channel subunit by photoreceptors in the rat retina. Mol. Vis. 7, 202–209.
Morrill J. A. and Cannon S. C. (1999) Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel, expressed in Xenopus laevis oocytes. J. Physiol. (Lond.) 520(Part 2), 321–336.
Morrill J. A., Brown R. H. Jr., and Cannon S. C. (1998) Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H. J. Neurosci. 18, 10,320–10,334.
Nechiporuk T., Huynh D. P., Figueroa K., Sahba S., Nechiporuk A., and Pulst S. M. (1998) The mouse SCA2 gene: cDNA sequence, alternative splicing and protein expression. Hum Mol. Genet. 7, 1301–1309.
Ng T. M., Kohli A., Fagan S. C. Mohamed A. E., and Geiszt G. (2000) The effect of intravenous verapamil on cerebral hemodynamics in a migraine patient with hemiplegia. Ann. Pharmacother. 34, 39–43.
Ophoff R. A., Terwindt G. M., Vergouwe M. N., et al. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543–552.
Piedras-Renteria E. S., Watase K., Harata N., et al. (2001) Increased expression of α1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6. J. Neurosci. 21, 9185–9193.
Pietrobon D. (2005a) Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr. Opin. Neurobiol. 15, 257–265.
Pietrobon D. (2005b) Migraine: new molecular mechanisms. Neuroscientist 11, 373–386.
Prod'hom B., Pietrobon D., and Hess P. (1987) Direct measurement of proton transfer rates to a group controlling the dihydropyridine-sensitive Ca2+ channel. Nature 329, 243–246.
Ptacek L. J., Tawil R., Griggs R. C., et al. (1994) Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77, 863–868.
Pulst S. M., Nechiporuk A., Nechiporuk T., et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spincocerebellar ataxia type 2. Nat. Genet. 14, 269–276.
Pulst S. M., Santos N., Wang D., et al. (2005) Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 128, 2297–2303.
Restimito, S., Thompson R. M., Eliet J., et al. (2000) The polyglutamine expansion in spinocerebellar ataxia type 6 causes a β-subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus cocytes. J. Neurosci. 20, 6394–6403.
Rios E. and Brum G. (1987) Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature 325, 717–720.
Robinson R., Hopkins P., Carsana A., et al. (2003) Several interacting genes influence the malignant hyperthermiaphenotype. Hum. Genet. 112, 217, 218.
Robinson R. L., Monnier N., Wolz W., et al. (1997) A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees. Hum. Mol. Genet. 6, 953–961.
Sasaki H., Kojima H., Yabe I., et al. (1998) Neuropathological and molecular studies of spincocerebellar ataxia type 6 (SCA6). Acta Neuropathol. 95, 199–204.
Schleithoff L., Mehrke G., Reutlinger B., and Lehmann-Horn F. (1999) Genomic structure and functional expression of a human α2/δ calcium channel subunit gene (CACNA2). Genomics 61, 201–209.
Silver K. and Andermann F. (1993) Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology 43, 36–41.
Sipos I., Jurkat-Rott K., Harasztosi C., et al. (1995) Skeletal muscle DHP receptor mutations after calcium currents in human hypokalaemic periodic paralysis myotubes. J. Physiol. 483 (Part 2), 299–306.
Scancey S. D., Hildebrand M. E., Materek L. A., Bird T. D., and Snutch T. P. (2004) Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann. Neurol. 56, 213–220.
Stewart S. L., Hogan K., Rosenberg H., and Fletcher J. E. (2001) Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin. Genet. 59, 178–184.
Striessnig J., Hoda J. C., Koschak A., et al. (2004) L-type Ca2+ channels in Ca2+ channelopathies. Biochem. Biophys. Res. Commun. 322, 1341–1346.
Strom T. M., Nyakatura G., Apfelstedt-Sylla, E., et al. (1998) An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary right blindness. Nat. Genet. 19, 260–263.
Takano H., Cancel G., Ikeuchi T., et al. (1998) Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am. J. Hum. Genet. 63, 1060–1066.
Tawil R., McDermott M. P., Brown R. Jr., et al. (2000) Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann. Neurol. 47, 46–53.
Toru S., Murakoshi T., Ishikawa K., et al. (2000) Spinocerebellar ataxia type 6 mutation alters P-type calcium channel function. J. Biol. Chem. 275, 10,893–10,898.
Tricarico D., Servidei S., Tonali P., Jurkat-Rott K., and Camerino D. C. (1999) Impairment of skeletal muscle adenosine triphosphate-sensitive K+ chainnels in patients with hypokalemic periodic paralysis. J. Clin. Invest. 103, 675–682.
van den Maagdenberg A. M., Kors, E. E., Brunt E. R., et al. (2002) Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A gene. J. Neurol. 249, 1515–1519.
van den Maagdenberg A. M., Pietrobon D., Pizzorusso T., et al. (2004) A Cacnala knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41, 701–710.
Varadi G., Mori Y., Mikala G., and Schwartz A. (1995) Molecular determinants of Ca2+ channel function and drug action. Trends Pharmacol. Sci. 16, 43–49.
Walker D. and De Waard M. (1998) Subunit interaction sites in voltage-dependent Ca2+ channel strole in channel function. Trends Neurosci. 21, 148–154.
Wappl E., Koschak A., Poteser M., et al. (2002) Functional consequences of P/Q type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J. Biol. Chem. 277, 6960–6966.
Weiss R. G., O'Connell K. M., Flucher B. E., Allen P. D., Grabner M., and Dirksen R. T. (2004) Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III–IV loop on skeletal muscle EC coupling. Am. J. Physiol. Cell Physiol. 287, C1094-C1102.
Yu W. and Horowitz S. H. (2003) Treatment of sporadic hemiplegimigraine with calcium-channel blocker verapamil. Neurology 60, 120, 121.
Zhuchenko O., Bailey J., Bonnen P., et al. (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat. Genet. 15, 62–69.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Felix, R. Calcium channelopathies. Neuromol Med 8, 307–318 (2006). https://doi.org/10.1385/NMM:8:3:307
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/NMM:8:3:307